分子診斷市場按產品類型、應用、最終用戶和地區分類

2025 年全球分子診斷市場規模預估為 183.6 億美元，預計到 2032 年將達到 416.3 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 12.4%。

圖。

分子診斷是一個正在發展的領域，它利用分子層面的生物標記（生物標記）分析來檢測疾病、預測風險並確定新的治療方案。分子診斷已成為現代醫學的基本工具，幫助臨床醫生檢測和監測疾病並指導治療決策。透過 DNA序列測定和聚合酵素鏈鎖反應(PCR) 等技術檢測生物標記的能力徹底改變了醫學檢測並顯著改善了患者的治療效果。分子診斷技術的進步，加上基因定序成本的下降，正在推動其在各個應用領域的應用，包括傳染病檢查、腫瘤學和個人化醫療。持續的研究和發展有望進一步擴大分析能力，促進市場持續擴張。

市場動態

由於多種因素，全球分子診斷市場正在經歷強勁成長。世界各地慢性病和感染疾病的增加推動了對先進診斷技術的需求。分子診斷測試可以比傳統方法更早、更準確地發現疾病。個人化醫療和伴同性診斷的需求不斷成長也是一個關鍵促進因素，因為分子測試有助於確定對個別患者最有效的治療方法。由於技術進步實現了更高通量篩檢、自動化工作流程和分散測試環境，分子診斷能力正在不斷擴大。然而，測試設備成本高和技術純熟勞工的短缺阻礙了市場的成長。定序成本的持續降低和可攜式、易於使用的儀器的開發為新的應用領域開闢了機會，特別是在分散的照護現場環境中。

研究的主要特點

本報告對全球分子診斷市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。

它強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全球分子診斷市場的主要企業。

本研究涉及的主要企業包括雅培實驗室、碧迪公司、生物梅里埃公司、丹納赫集團、Diasorin SPA、Hologic 公司、凱傑公司和羅氏診斷公司。

本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

相關人員將透過全球分子診斷市場分析中使用的各種策略矩陣來做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要

第3章市場動態、法規與趨勢分析

• 市場動態
• 影響分析
• 監管情景
• 產品發布/核准
• PEST分析
• 波特分析
• 併購情景

4. 2025-2032 年全球分子診斷市場（按產品類型分類）（十億美元）

• 介紹
• 試劑和套件
• 裝置

5. 全球分子診斷市場，按應用分類，2025-2032 年（十億美元）

• 介紹
• 腫瘤學
• 基因檢測
• 微生物學
• 性行為感染傳染病
• 血液檢查
• 病毒學
• 組織學分型
• 產前檢查
• 其他

6. 2025-2032 年全球分子診斷市場（按最終用戶分類）（十億美元）

• 介紹
• 醫院和診斷實驗室
• 學術研究所
• 製藥和生物技術公司
• 合約研究組織 (CRO)
• 照護現場環境

7. 2020 年至 2032 年全球分子診斷市場按地區分類的金額（十億美元）

• 介紹
• 北美洲
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲國家
• 歐洲
• 德國
• 英國
• 西班牙
• 法國
• 義大利
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 中國
• 印度
• 日本
• 澳洲
• 韓國
• 東南亞國協
• 其他亞太地區
• 中東
• 海灣合作理事會國家
• 以色列
• 其他中東地區
• 非洲
• 南非
• 北非
• 中部非洲

第8章 競爭格局

• Hoffmann-La Roche Ltd
• Illumina, Inc.
• Hologic, Inc.
• Agilent Technologies Inc.
• Qiagen NV
• Myriad Genetics
• Becton, Dickinson and Company
• Abbott Laboratories
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• Sysmex Corporation
• Danaher Corporation（Beckman Coulter Inc.）
• Thermo Fisher Scientific Inc.
• Siemens Healthineers AG
• Johnson & Johnson
• Alere Inc.
• Cepheid
• Gen-Probe Incorporated
• LabCorp（Monogram Biosciences）
• Novartis AG

第 9 章分析師建議

• 興衰
• 一致的機會地圖

第10章參考文獻與調查方法

• 參考
• 調查方法
• 關於出版商

Global Molecular Diagnostics Market is estimated to be valued at USD 18.36 Bn in 2025 and is expected to reach USD 41.63 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.4% from 2025 to 2032.

Figure. Molecular Diagnostics Market Share (%), By Region 2025

Molecular diagnostics is an evolving field that involves the analysis of biological markers, or biomarkers, at the molecular level to test for diseases, predict risk or identify new therapeutic options. Molecular diagnostics has become a fundamental tool in modern healthcare, helping clinicians detect and monitor disease along with making treatment decisions. The ability to detect biomarkers through techniques such as DNA sequencing and polymerase chain reaction (PCR) has revolutionized medical testing and significantly improved patient outcomes. Advances in molecular diagnostic techniques coupled with the declining costs of genetic sequencing are helping drive widespread adoption across various applications areas such as infectious disease testing, oncology and personalized medicine. Continued research and development is further expanding analytical capabilities which is expected to contribute to the ongoing expansion of the market.

Market Dynamics:

The global molecular diagnostics market is witnessing strong growth driven by several factors. Rising prevalence of chronic and infectious diseases worldwide have increased the need for advanced diagnostic techniques. Molecular diagnostic tests offer earlier, more accurate detection of diseases compared to conventional methods. Growing demand for personalized medicine and companion diagnostics is another key driver as molecular tests help identify the most effective therapies for individual patients. Technological advancements enabling high-throughput screening, automated workflow processes and decentralized testing environments are expanding molecular diagnostic capabilities. However, high costs of instruments and lack of skilled labor restrain the market growth. Ongoing reductions in sequencing costs along with the development of portable, easy-to-use instruments opens opportunities in new applications areas, especially in decentralized, point-of-care settings.

Key Features of the Study:

This report provides in-depth analysis of the global molecular diagnostics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global molecular diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott Laboratories, Becton, Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin SPA, Hologic Inc., QIAGEN N.V., Roche Diagnostics.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global molecular diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular diagnostics market.

Detailed Segmentation-

• By Product Type
  • Reagents & Kits
  • Instruments
• By Application
  • Oncology
  • Genetic Testing
  • Microbiology
  • STDs
  • Blood Screening
  • Virology
  • Tissue Typing
  • Prenatal Diagnosis
  • Others
• By End-user
  • Hospitals and Diagnostic Laboratories
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Point-of-Care Settings
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Key Players Insights
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Hologic, Inc.
  • Agilent Technologies Inc.
  • Qiagen N.V.
  • Myriad Genetics
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Sysmex Corporation
  • Danaher Corporation (Beckman Coulter Inc.)
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Johnson & Johnson
  • Alere Inc.
  • Cepheid
  • Gen-Probe Incorporated
  • LabCorp (Monogram Biosciences)
  • Novartis AG

Table of Contents

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

• Research Objectives
• Assumptions
• Abbreviations

2. MARKET PURVIEW

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Molecular Diagnostics Market, By Product Type
  • Global Molecular Diagnostics Market, By Application
  • Global Molecular Diagnostics Market, By End-User
  • Global Molecular Diagnostics Market, By Region

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Molecular Diagnostics Market, By Product Type, 2025-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Reagents & Kits
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Molecular Diagnostics Market, By Application, 2025-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Genetic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Microbiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• STDs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Blood Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Virology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Tissue Typing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Prenatal Diagnosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Molecular Diagnostics Market, By End-User, 2025-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals and Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Point-of-Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Molecular Diagnostics Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD Bn)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD Bn)
• South Africa
• North Africa
• Central Africa

8. COMPETITIVE LANDSCAPE

• Hoffmann-La Roche Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Illumina, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hologic, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Qiagen N.V.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Myriad Genetics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• bioMerieux SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories, Inc.
• Sysmex Corporation
• Danaher Corporation (Beckman Coulter Inc.)
• Thermo Fisher Scientific Inc.
• Siemens Healthineers AG
• Johnson & Johnson
• Alere Inc.
• Cepheid
• Gen-Probe Incorporated
• LabCorp (Monogram Biosciences)
• Novartis AG

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us